Table 1.
Distribution of COVID-19 Cases and non-COVID-19 Diseases.
| Training and Validation Dataset (n patients) | Disease | Test Dataset (n patients) |
|---|---|---|
| 165 | COVID-19 | 45 |
| 12 (7 %) | Bacterial Pneumonia | 8 (18 %) |
| 4 (2 %) | Pneumocystis Pneumonia | 2 (4 %) |
| 2 (1 %) | Viral Pneumonia | 5 (11 %) |
| 8 (5 %) | Other infectious diseases (Klebsiella pneumonia, Bronchiolitis, mycobacterium avium complex infection, fungal pneumonia, etc.) | 15 (33 %) |
| 1 (0,6 %) | Abscess | 5 (11 %) |
| 21 (13 %) | Lung cancer and metastasis | 9 (20 %) |
| 5 (3 %) | Idiopathic pulmonary fibrosis | |
| 8 (5 %) | Organizing Pneumonia | |
| 3 (2 %) | Lipoid Pneumonia | |
| 5 (3 %) | Diffuse pulmonary haemorrhage and trauma | 1 (2 %) |
| 5 (3 %) | Hypersensitivity pneumonitis | |
| 5 (3 %) | Pulmonary edema | |
| 2 (1 %) | ARDS | |
| 86 (51 %) | Other (Aspergillosis, Sarcoidosis, Histioplasmosis, Silicosis, eosinophilic pneumonia, Granulomatosis with polangitis, drug induced lung disease, Giant cell interstitial pneumonia, Cystic fibrosis, etc.) |